PK Study in Patients With Parkinson's Disease With IZD174
NCT04338997
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Strategic decision by Sponsor
Conditions
Parkinson Disease
Interventions
DRUG:
IZD174
Sponsor
Inflazome UK Ltd